American Vanguard AVD
- Market cap
- $30.4M
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 0.1×
- EV/EBIT
- 10.9×
- Revenue, 12 months
- $510.3M
- −4% on a year ago
- Net margin
- −10.7%
- Free cash flow yield
- −154.8%
American Vanguard trades at 0.1× sales. Its trailing earnings are negative, so it has no PE. Revenue was $510.3M over the last twelve months, down 4% on a year earlier with a −11% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $149.5M−2% | $172.2M+8% | $135.1M+8% | $128.2M−3% | $118.3M−21% | $165.6M−4% | $115.8M−14% | $129.3M+1% | $119.3M+1% | $150.7M−9% | $123.6M+7% | $116.8M−10% | |
| Cost of revenue | $106.4M+4% | $117.5M+0% | $92.7M+7% | $90.4M+1% | $101M−5% | $142.8M+22% | $85.6M−8% | $88.8M−2% | $85.1M−16% | $108.1M−24% | $85.2M−1% | $82M−8% |
| Gross profit | $43.1M−13% | $54.6M+30% | $42.4M+10% | $37.8M−12% | $17.3M−60% | $22.8M−58% | $30.2M−29% | $40.5M+7% | $34.2M+98% | $42.6M+87% | $38.4M+27% | $34.7M−14% |
| R&D | $9.1M | $10.7M | $5.7M−36% | $8.6M−9% | $11.2M+23% | $7.2M−33% | $5.7M−0% | $5.8M−33% | $5.7M−49% | $6M−16% | $5.3M−7% | $6.5M+12% |
| SG&A | $29.8M | $30.9M | $29.5M+12% | $31.1M+4% | $26.4M−12% | $32.7M+6% | $26.6M−10% | $28.6M−8% | $26.7M+1% | $28.6M−13% | $27.7M+4% | $26.6M−7% |
| $4.2M−63% | $12.1M+214% | $6.1M+87% | −$9.2M | −$28.4M | −$70M | −$4.3M | $4.4M | −$6.5M−77% | −$21.8M−69% | $1.9M | −$303K | |
| Interest expense | $3.4M+212% | $4.4M+157% | $3.7M+119% | $3.9M+22% | $4.4M+29% | $4.6M+5% | $3.8M+2% | $4.5M+14% | $4.9M+12% | $5.3M+17% | $5.8M+54% | $9.1M+105% |
| Pre-tax income | $560K−94% | $7.7M+239% | $3M+95% | −$13.3M | −$32.8M | −$77.5M | −$8.1M | −$84K−99% | −$11.9M−64% | −$27.1M−65% | −$4M−50% | −$9.5M+11192% |
| $885K−70% | $712K | $1.5M | −$1.6M | −$7M | $13M+1722% | $387K−74% | $765K | $422K | $1.1M−92% | $124K−68% | $383K−50% | |
| Net income | −$325K | $7M+79% | $1.6M−19% | −$11.7M+1013% | −$25.7M+7821% | −$90.4M | −$8.5M | −$849K−93% | −$12.4M−52% | −$28.2M−69% | −$4.1M−51% | −$9.9M+1062% |
| −$0.01 | $0.25+92% | $0.06−14% | −$0.42+950% | −$0.91+9000% | −$3.21 | −$0.30 | −$0.03−93% | −$0.43−53% | −$0.99−69% | −$0.14−53% | −$0.34+1033% | |
| 27.9M−6% | 28.2M−3% | 28.1M−3% | 28M−1% | 28.2M+1% | 28.2M+0% | 28.3M+1% | 28.3M+1% | 28.5M+1% | 28.6M+1% | 28.6M+1% | 28.6M+1% |
EPS, diluted: 7 periods, Q4 FY10 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 14 periods, Q4 FY10 to Q4 FY23: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY24 and Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Basic Materials nearest American Vanguard's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| AVDAmerican Vanguard | $30.4M | n/m | 30.2× | 0.1× | −4% | −10.7% | |
| BTMDbiote | $38.4M | 10.7× | 12.3× | 0.2× | −8% | 3.2% | |
| BWENBroadwind | $68.6M | n/m | 12.9× | 0.5× | +17% | 3.9% | |
| FTLFFitlife Brands | $78.4M | 13.5× | 15.3× | 0.8× | +61% | 6.2% | |
| SMIDSmith Midland | $112.9M | 14.7× | 18.2× | 1.3× | −2% | 8.6% | |
| NAGENiagen Bioscience | $192.3M | 13.5× | 27.0× | 1.5× | +11% | 12.4% | |
| SNDSmart Sand | $201.8M | 18.3× | 12.5× | 0.5× | +27% | 2.7% | |
| ALTOAlto Ingredients | $280M | 5.4× | 13.8× | 0.3× | +1% | 5.5% | |
| FRDFriedman Industries | $301.7M | 10.9× | 9.3× | 0.4× | +62% | 3.6% | |
| IDRIdaho Strategic Resources | $303.5M | 13.5× | 25.5× | 6.0× | +67% | 44.0% | |
| Peer median | $192.3M | 13.5× | 13.8× | 0.5× | +17% | 5.5% |
More on American Vanguard
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #2of 159Materials stocks with the lowest price to sales ratio
- #1of 19Agricultural Inputs stocks with the lowest price to sales ratio
- #6of 11Agricultural Inputs stocks with the lowest EV/EBIT
- #10of 13Agricultural Inputs stocks with the fastest revenue growth
Its groups
About
- Industry
- Agricultural Inputs
- Sector
- Basic Materials
Valuation data, not investment advice. Prices as of .